These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option. Yoon KH. Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225 [Abstract] [Full Text] [Related]
5. [Prospects of the use of cyclosporin A in rheumatic diseases]. Nasonov EL, Shtutman VZ, Nasonova VA. Klin Med (Mosk); 1994 Oct; 72(5):12-9. PubMed ID: 7853807 [No Abstract] [Full Text] [Related]
6. Drug therapy in the rheumatic diseases. Reardon EV, Clough JD. Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055 [No Abstract] [Full Text] [Related]
9. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI). Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531 [Abstract] [Full Text] [Related]
12. [Controlled clinical research on the use of ibuprofen in rheumatoid arthritis and other rheumatic diseases]. Giordano M, Tirri G, Capelli L, Gallo M, Scott GG. Minerva Med; 1973 Jun 23; 64(47):2483-90. PubMed ID: 4579840 [No Abstract] [Full Text] [Related]